References

A novel coronavirus from patients with pneumonia in China, 2019

10.1056/nejmoa2001017 · 2020 · External reference

Unresolved reference

External reference

Unresolved reference

2022 · External reference

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

10.1183/13993003.01398-2020 · 2020 · External reference

Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts

10.1016/j.pulmoe.2020.05.002 · 2020 · External reference

Unresolved reference

2022 · External reference

Unresolved reference

External reference

Latent Mycobacterium tuberculosis infection

10.1056/nejmra1405427 · 2015 · External reference

Latent tuberculosis infection

10.1056/nejmcp2108501 · 2021 · External reference

Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis

10.1136/bmj.m549 · 2020 · External reference

The global prevalence of latent tuberculosis: a systematic review and meta-analysis

10.1183/13993003.00655-2019 · 2019 · External reference

Role of TNF-Alpha, IFN-Gamma, and IL-10 in the development of pulmonary tuberculosis

10.1155/2012/745483 · 2012 · External reference

The granuloma in tuberculosis: dynamics of a host-pathogen collusion

10.3389/fimmu.2012.00411 · 2012 · External reference

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis

10.1016/j.ijid.2020.04.086 · 2020 · External reference

Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2

10.1371/journal.ppat.1010093 · 2022 · External reference

Co-infection of mice with SARS-CoV-2 and Mycobacterium tuberculosis limits early viral replication but does not affect mycobacterial loads

10.3389/fimmu.2023.1240419 · 2023 · External reference

Superinfection with SARS-CoV-2 has deleterious effects on Mycobacterium bovis BCG immunity and promotes dissemination of Mycobacterium tuberculosis

10.1128/spectrum.03075-22 · 2022 · External reference

Localized and systemic immune responses against SARS-CoV-2 following mucosal immunization

10.3390/vaccines9020132 · 2021 · External reference

Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice

10.3390/v13010132 · 2021 · External reference

Protection by novel vaccine candidates, Mycobacterium tuberculosis DeltamosR and DeltaechA7, against challenge with a Mycobacterium tuberculosis Beijing strain

10.1016/j.vaccine.2015.08.084 · 2015 · External reference

Characterization of immune cell populations in the tumor microenvironment of colorectal cancer using high definition spatial profiling

2024 · External reference

Dictionary learning for integrative, multimodal and scalable single-cell analysis

10.1038/s41587-023-01767-y · 2024 · External reference

sccomp: Robust differential composition and variability analysis for single-cell data

10.1073/pnas.2203828120 · 2023 · External reference

clusterProfiler: an R package for comparing biological themes among gene clusters

10.1089/omi.2011.0118 · 2012 · External reference

Mouse and Guinea pig models of tuberculosis

10.1128/9781555819569.ch7 · 2016 · External reference

Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling

10.1128/jb.00011-07 · 2007 · External reference

Systemic neutralizing antibodies and local immune responses are critical for the control of SARS-CoV-2

10.3390/v14061262 · 2022 · External reference

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

10.1073/pnas.0506580102 · 2005 · External reference

The gene ontology knowledgebase in 2023

10.1093/genetics/iyad031 · 2023 · External reference

Gene Ontology: tool for the unification of biology

10.1038/75556 · 2000 · External reference

Targeting innate immunity for tuberculosis vaccination

10.1172/jci128877 · 2019 · External reference

B cells promote granulomatous inflammation during chronic Mycobacterium tuberculosis infection in mice

10.1371/journal.ppat.1011187 · 2023 · External reference

Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis

10.1002/jmv.26311 · 2021 · External reference

Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa

10.1093/cid/ciab803 · 2021 · External reference

Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study

10.1016/s2352-3018(21)00151-x · 2021 · External reference

Tuberculosis and COVID-19 co-infection: description of the global cohort

10.1183/13993003.02538-2021 · 2022 · External reference

Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice

10.1177/03009858211066841 · 2022 · External reference

Impact of COVID-19 pandemic on TB prevention and care in Addis Ababa, Ethiopia: a retrospective database study

10.1136/bmjopen-2021-053290 · 2022 · External reference

The temporal expression profile of Mycobacterium tuberculosis infection in mice

10.1073/pnas.0306023101 · 2004 · External reference

Profiling early lung immune responses in the mouse model of tuberculosis

10.1371/journal.pone.0016161 · 2011 · External reference

Host immunity to Mycobacterium tuberculosis and risk of tuberculosis: A longitudinal study among Greenlanders

10.1016/j.vaccine.2016.09.047 · 2016 · External reference

Cell-mediated immune responses to in vivo-expressed and stage-specific Mycobacterium tuberculosis antigens in latent and active tuberculosis across different age groups

10.3389/fimmu.2020.00103 · 2020 · External reference

Global incidence of neurological manifestations among patients hospitalized with COVID-19-a report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

10.1001/jamanetworkopen.2021.12131 · 2021 · External reference

Neurologic findings among inpatients with COVID-19 at a safety-net US hospital

10.1212/cpj.0000000000001031 · 2021 · External reference

Neurologic manifestations of long COVID differ based on acute COVID-19 severity

10.1002/ana.26649 · 2023 · External reference

Fatal central nervous system co-infection with SARS-CoV-2 and tuberculosis in a healthy child

10.1186/s12887-020-02308-1 · 2020 · External reference

A 28-year-old man from India with SARS-Cov-2 and pulmonary tuberculosis co-infection with central nervous system involvement

10.12659/ajcr.926034 · 2020 · External reference

Presentations and outcomes of central nervous system TB in a UK cohort: The high burden of neurological morbidity

10.1016/j.jinf.2020.10.028 · 2021 · External reference

Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model

10.1016/j.ijantimicag.2017.08.020 · 2018 · External reference

Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice

10.1016/j.ajpath.2014.03.008 · 2014 · External reference

For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection

10.1111/j.1600-065x.2010.00994.x · 2011 · External reference

Revisiting the role of the granuloma in tuberculosis

10.1038/nri3211 · 2012 · External reference

Cytokines and chemokines in mycobacterium tuberculosis infection

10.1128/microbiolspec.tbtb2-0018-2016 · 2016 · External reference

Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice

10.1038/s41467-024-54334-7 · 2024 · External reference

IL-22: an underestimated player in natural resistance to tuberculosis

10.3389/fimmu.2018.02209 · 2018 · External reference

Insights on the role of the chemokine CCL8 in pathology

10.1016/j.cellsig.2025.111951 · 2025 · External reference

Molecular biology of BPIFB1 and its advances in disease

10.21037/atm-20-3462 · 2020 · External reference

BPIFB1 (LPLUNC1) is upregulated in cystic fibrosis lung disease

10.1007/s00418-012-0990-8 · 2012 · External reference

Differential expression of viral transcripts from single-cell RNA sequencing of moderate and severe COVID-19 patients and its implications for case severity

10.3389/fmicb.2020.603509 · 2020 · External reference

Involvement of Bradykinin and Folate receptor in calming the SARS-COV2 cytokine storm: Lessons learnt from lung cancer

10.21203/rs.3.rs-23656/v1 · 2020 · External reference

Pro-inflammatory granzyme K contributes extracellularly to disease

10.3389/fimmu.2025.1620670 · 2025 · External reference

Early response of CD8+ T cells in COVID-19 patients

10.3390/jpm11121291 · 2021 · External reference

CD8 T cells and Mycobacterium tuberculosis infection

10.1007/s00281-015-0490-8 · 2015 · External reference

Role of B cells in mycobacterium tuberculosis infection

10.3390/vaccines11050955 · 2023 · External reference

Unraveling the role of the immune landscape in tuberculosis granuloma

10.1016/j.tube.2025.102615 · 2025 · External reference

Tertiary lymphoid structures in tuberculosis: persistence, protection, and pathology

10.1111/imr.70055 · 2025 · External reference

T-cell–B-cell collaboration in the lung

10.1016/j.coi.2023.102284 · 2023 · External reference

Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages

10.1371/journal.ppat.1007060 · 2018 · External reference

Foam cell macrophages in tuberculosis

10.3389/fimmu.2021.775326 · 2021 · External reference

Foam cells control mycobacterium tuberculosis infection

10.3389/fmicb.2020.01394 · 2020 · External reference